AAAAAA

   
Results: 1-13 |
Results: 13

Authors: PELTOLA J HURME M MIETTINEN A KERANEN T
Citation: J. Peltola et al., ELEVATED LEVELS OF INTERLEUKIN-6 MAY OCCUR IN CEREBROSPINAL-FLUID FROM PATIENTS WITH RECENT EPILEPTIC SEIZURES, Epilepsy research, 31(2), 1998, pp. 129-133

Authors: PELTOLA J HAAPALA AM KERANEN T LATVALA K ISOJARVI J
Citation: J. Peltola et al., ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH EPILEPSY, Neurology, 50(4), 1998, pp. 6069-6069

Authors: PELTOLA J KERANEN T
Citation: J. Peltola et T. Keranen, INTERFERON-BETA IN MULTIPLE-SCLEROSIS - SOME FORM OF COMPROMISE MUST BE ACCEPTED, BMJ. British medical journal, 314(7080), 1997, pp. 602-602

Authors: KERANEN T GORDIN A KOULU M SCHEININ M ANTILA S SUNDBERG S WIKBERG T
Citation: T. Keranen et al., COMT INHIBITION BY ENTACAPONE DOES NOT AFFECT GROWTH-HORMONE OR PROLACTIN SECRETION IN HEALTHY-VOLUNTEERS, Journal of neural transmission, 103(6), 1996, pp. 729-736

Authors: FORSS N MAKELA JP KERANEN T HARI R
Citation: N. Forss et al., TRIGEMINALLY TRIGGERED EPILEPTIC HEMIFACIAL CONVULSIONS, NeuroReport, 6(6), 1995, pp. 918-920

Authors: KERANEN T MOBIUS HJ SCHURREISINGER S PELTOLA J ISOJARVI J MURROS K SAANO V ANDERSSON P MENGE G EZZET F SCWABE S
Citation: T. Keranen et al., EFFECT OF OXCARBAZEPINE ON HEPATIC-CLEARANCE OF ANTIPYRINE IN PATIENTS WITH PREVIOUSLY UNTREATED EPILEPSY, Epilepsia, 36, 1995, pp. 161-161

Authors: KERANEN T RIIHIMAKI J
Citation: T. Keranen et J. Riihimaki, SEIZURES AND FAINTS - AN EVALUATION OF 259 PATIENTS WITH TRANSIENT LOSS OF CONSCIOUSNESS, Epilepsia, 36, 1995, pp. 209-209

Authors: KORPINEN L PIETILA T PELTOLA J NISSILA M KERANEN T TUOVINEN T FALCK B PETRANEK ES FREY H
Citation: L. Korpinen et al., EVALUATION OF EPILEPSY EXPERT - A DECISION-SUPPORT SYSTEM, Computer methods and programs in biomedicine, 45(3), 1994, pp. 223-231

Authors: KERANEN T GORDIN A KARLSSON M KORPELA K PENTIKAINEN PJ RITA H SCHULTZ E SEPPALA L WIKBERG T
Citation: T. Keranen et al., INHIBITION OF SOLUBLE CATECHOL-O-METHYLTRANSFERASE AND SINGLE-DOSE PHARMACOKINETICS AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF ENTACAPONE, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 151-157

Authors: KERANEN T RIEKKINEN PJ
Citation: T. Keranen et Pj. Riekkinen, REMISSION OF SEIZURES IN UNTREATED EPILEPSY, BMJ. British medical journal, 307(6902), 1993, pp. 483-483

Authors: SUNDBERG S SCHEININ M ILLI A AKKILA J GORDIN A KERANEN T
Citation: S. Sundberg et al., THE EFFECTS OF THE COMT INHIBITOR ENTACAPONE ON HEMODYNAMICS AND PERIPHERAL CATECHOLAMINE METABOLISM DURING EXERCISE, British journal of clinical pharmacology, 36(5), 1993, pp. 451-456

Authors: MYLLYLA VV SOTANIEMI KA ILLI A SUOMINEN K KERANEN T
Citation: Vv. Myllyla et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS OF LEVODOPA AND ON CARDIOVASCULAR-RESPONSES IN PATIENTS WITH PARKINSONS-DISEASE, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 419-423

Authors: KALVIAINEN R KERANEN T RIEKKINEN PJ
Citation: R. Kalviainen et al., PLACE OF NEWER ANTIEPILEPTIC DRUGS IN THE TREATMENT OF EPILEPSY, Drugs, 46(6), 1993, pp. 1009-1024
Risultati: 1-13 |